Vanderbilt Hereditary Colorectal Cancer Registry
OBJECTIVES:
Primary
- To identify patients and their family members who have either hereditary colorectal
cancer or polyposis syndrome or are at high risk for developing hereditary colorectal
cancer.
Secondary
- To establish a tissue and data repository that will be used to further research in
hereditary colorectal cancer syndromes.
OUTLINE: Data is collected on patients and their families for inclusion in a hereditary
colorectal cancer registry. Registry data is entered into a secure database that includes
information on patient demographics and medical and family cancer history. The information
collected will be used to formulate screening and surveillance recommendations, to further
knowledge of hereditary colorectal cancer, and to facilitate cancer research. Registry data
will also be used to improve the quality of current standard of care through timely tracking
and notification of patients for follow-up care, identification of registry participants at
high risk for developing an inherited form of colon cancer, and by serving as a resource for
future research.
Registry patients may undergo optional blood, urine, and/or sputum sample collection for
inclusion in the tissue repository. Tissue samples from a previous biopsy may also be
obtained. Samples will be stored for future research studies.
Observational
Time Perspective: Prospective
Identification of patients at high risk of developing hereditary colorectal cancer
Database will continue indefinitely with IRB approval and investigator support
continuous data collection
No
Paul Wise, MD
Study Chair
Vanderbilt-Ingram Cancer Center
United States: Vanderbilt Institutional Review Board and Human Research Protection Program
CDR0000587344
NCT00675636
January 2007
Name | Location |
---|---|
Vanderbilt-Ingram Cancer Center | Nashville, Tennessee 37232-6838 |
Vanderbilt-Ingram Cancer Center - Cool Springs | Nashville, Tennessee 37064 |
Vanderbilt-Ingram Cancer Center at Franklin | Nashville, Tennessee 37064 |